Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses

Detalles Bibliográficos
Autores principales: Srivastava, Minu, Murriel, Christopher, Yun, Rui, Mayes, Erin, Jie, Hyun-Bae, Axelrod, Fumiko, Xie, Ming-Hong, Bentley, Trevor, Cancilla, Belinda, Tam, Raymond, O'Young, Gilbert, Kapoun, Ann, Lewicki, John, Hoey, Tim, Gurney, Austin, Inkyung, Park Angie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649383/
http://dx.doi.org/10.1186/2051-1426-3-S2-P373
Descripción
Sumario:

Ejemplares similares